Manchester research leads to NHS roll out of life-saving treatment for babies with rare disease
Babies and toddlers with a rare and fatal genetic condition can now receive life-saving treatment on the NHS for the first time.
Read moreResearch and innovation news
Keep up-to-date with the latest news, publications and events from the Research and Innovation team at MFT.
‘Getting the dose right’ – A blog by Dr Jan Hansel
For World Antimicrobial Awareness Week, Dr Jan Hansel discusses the importance of therapeutic drug monitoring (TDM) in limiting the development of antimicrobial resistance and the new TDM-TIME study.
Read more
Manchester University NHS Foundation Trust to host new NIHR Regional Research Delivery Network
The Department of Health and Social Care has announced that a new NIHR Research Delivery Network will commence in 2024 to support the successful delivery of health and social care research in England.
Read more
MFT awarded £3m to develop innovative technology solutions to improve health outcomes in Greater Manchester
NIHR has awarded MFT £2,998,433 from 1 April 2024 to develop innovative technology solutions for better diagnosis, treatment, and care for people across our region.
Read more
Spotlight On: Dr Fozia Ahmed, Consultant Cardiologist
In the latest Spotlight On blog, Dr Ahmed discusses the breakthrough STEP HFpEF study and the importance of equality, diversity and inclusivity in research, sharing her first-hand experiences of this.
Read more
Groundbreaking gene therapy trial for Hunter syndrome opens
The UK regulatory authorities have approved the first ever trial of a revolutionary gene therapy for young children diagnosed with Hunter syndrome, a devastating rare lysosomal storage disorder.
Read more
Life after treatment: ITV follow up with Teddi, the first child in the UK to receive NHS life-saving gene therapy
ITV Tyne Tees and Granada Reports recently featured the journey of two-year-old Teddi Shaw, who became the first child in the UK to receive NHS life-saving gene therapy treatment, Libmeldy® at MFT.
Read more
Tour of the TAP run for Cure Leukaemia takes place at MFT
R&I colleagues welcomed James McLaughlin, Chief Executive for Cure Leukaemia, to MFT, as he ran 14 km across Manchester to raise funds for blood cancer research at Manchester Royal Infirmary (MRI).
Read more
